Actimarbo 80 mg Flavoured Tablets for Dogs
Country: Spain
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
22-08-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
marbofloxacin 80 mg
Available from:
Ecuphar N.V.
ATC code:
QJ01MA93
Pharmaceutical form:
Tablet
Therapeutic group:
marbofloxacin
Therapeutic area:
Dogs Non Food
Authorization date:
2013-06-26
Summary of Product characteristics
Issued: July 2013
AN: 00515/2012
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Actimarbo 80 mg Flavoured Tablets for Dogs (AT, CZ, DE, ES, IT, NL, PT, SK, UK)
Actimarbo 80 mg Tablets for Dogs (FR)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Marbofloxacin
80.0 mg per tablet
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Off white to beige brown spotted, capsule shaped uncoated tablet with break line on
both sides and embossed
“MV” and “80” on either side of break line on one side.
The tablets can be divided into halves.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For dogs, marbofloxacin is indicated in the treatment of:
Skin and soft tissue infections caused by susceptible strains of organisms.
Urinary tract infections (UTI) associated or not with prostatitis or epididymitis caused
by susceptible strains of organisms.
Respiratory infections, caused by susceptible strains of organisms.
4.3 CONTRAINDICATIONS
Marbofloxacin should not be used in dogs aged less than 12 months, or less than 18
months for exceptionally large breeds of dogs, such as Great Danes, Briard, Bernese,
Bouvier and Mastiffs, with a longer growth period.
Issued: July 2013
AN: 00515/2012
Page 2 of 7
Do not use in animals with known hypersensitivity to marbofloxacin or other
(fluoro)quinolones or to any of the excipients of the product.
Do not use in case of confirmed
Read the complete document
